FDA Investigator Carlos Chavez
Carlos Chavez has inspections in 1 countries as of 29 Sep 2023. Carlos Chavez has collaborated with a combined 1516 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan P Kurtzberg,
Amy C Jordan,
Andrea A Branche,
Andrea S Heise,
Arie C Menachem,
Bo Chi, PhD,
Carla C Cummins,
Carla C Tuite,
Cassandra L Abellard,
Christopher M Jenner,
Claudia Mperez Kasmarski,
Cynthia F Kleppinger, MD,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Dr. Sriram Subramaniam, PhD,
Dustin M James,
Edith M Gonzalez,
Edmund F Mrak, Jr,
Elizabeth D Connell,
Erika V Butler,
Gam S Zamil,
Ginger M Sykes,
H Ljamilla Selby,
Hala L Selby,
Hung V Le,
Iris C Macinnes,
Jamie L Dion,
Jocelyn C Turner,
Jodi M Gatica,
Joey V Quitania,
John P Mistler,
Jose O Hernandez,
Jose Ohernandez Guzman,
Justine M Corson,
Karen Mcnabb Noon,
Kimberley A Hoefen,
Lakecha N Lewis,
Langer,
LCDR Debra Emerson,
Leo B Zadecky,
Linda F Murphy,
Linda Thai,
Lisa Shin,
Lori M Newman,
Margaret M Annes,
Marion W Nadeau,
Mark R Mcclain,
Matthew R Dionne,
Megan A Haggerty,
Melissa G Gonzalez,
Michael A Charles,
Michael J Casey,
Michael J Kuchta,
Michael R Goga,
Michelle A Krayer,
Nayan J Patel,
Nealie C Newberger,
Philip M Steele, PhD,
Qing Delgado,
Ramon E Martinez,
Richard B Mcaroy,
Richard H Penta,
Ricki A Chase,
Robert J Martin,
Rory K Geyer,
Scott T Ballard,
Sean C Johnson,
Sha'tina R Alridge,
Shanna N Purdy,
Sherrie L Krolczyk,
Stacey S Degarmo,
State Agency,
Stephen D Brown,
Stephen T Hansen,
Thomas J Slayt,
Torrance J Slayton,
Trina K Vick,
Truong Xuan Nguyen (Andy),
Uduak M Inokon,
Virgilio F Pacio, CSO,
William J Leonard,
Yasamin Ameri,
Yiyue Zhang (nmi), PhD,
Yumi J Hiramine,
Zachary A Bogorad,
Zachary L Miller
Carlos Chavez's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2015 | FDA 483 | Medline Industries Inc. - Form 483, 2015-06-01 |
July, 2015 | FDA 483 Response | Pharma Nobis, LLC - Form 483R, 2015-07-21 |
July, 2015 | FDA 483 | Pharma Nobis, LLC - Form 483, 2015-07-01 |
August, 2015 | FDA 483 | Alexion Pharmaceuticals, Inc. - Form 483, 2015-08-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more